Patent expiry incruse?

Why do some drug patents last longer than the 20‑year rule?
A patent normally expires 20 years from its filing date, but the U.S. Food and Drug Administration can extend that life through Patent Term Extension (PTE) or Patent Term Restoration (PTR). PTE adds up to 5 years to compensate for FDA review delays, while PTR can add up to 4 years if regulatory review takes longer than 14 months after the drug’s approval date. These extensions keep the patent active while the company still collects sales profits [1].

How does the FDA’s patent term extension work?
When a drug reaches the end of its 20‑year term, the company files a PTE request that calculates the delay in the approval process. If the delay exceeds a threshold, the FDA awards a partial extension, up to 5 years. The calculation subtracts the period of pre‑marketing clinical trials and the time taken for the FDA to review the new drug application (NDA) or biologics license application (BLA). The extension applies only to the specific product and does not affect other drugs in the same class [1].

What role does exclusivity play when a patent is about to expire?
Even after a patent expires, a drug can still enjoy market protection through data exclusivity or orphan‑drug exclusivity. For example, a 5‑year data exclusivity period begins upon FDA approval and blocks generic manufacturers from filing an Abbreviated New Drug Application (ANDA) that relies on the brand‑name data. Orphan‑drug exclusivity can last 7 years. These exclusivity periods can delay the entry of generics for several years after the patent expires [1].

Can a company file for new patents after the original expires?
Yes. A firm may secure additional patents on new formulations, delivery devices, or improved manufacturing processes. These new patents can extend the product’s life by creating new legal barriers for competitors. However, each new patent is subject to the same 20‑year life limit and must be filed before that deadline to be effective [1].

What happens to patients and prices when a patent finally expires?
When a patent expires and exclusivity ends, generic manufacturers can submit ANDAs, and a generic version is usually priced 20‑30 % lower than the brand‑name drug. The market often sees a rapid price drop within 90–120 days of the generic’s launch. Patients and insurers benefit from lower copayments and better coverage, although some may experience a temporary supply shortage during the transition [1].

When can a drug’s patent term be extended by more than five years?
In rare cases, companies can request a combined PTE and PTR, allowing a total of up to 9 years of extension beyond the 20‑year baseline. This occurs when the drug’s regulatory pathway is exceptionally lengthy and the FDA grants both extensions. The combined extension is applied in two separate filings and is only available for certain therapeutic classes or specialty drugs [1].

Is there a risk that a patent will never expire?
Patents are finite and eventually expire, but litigation or re‑filing of new claims can delay competition. A company may sue to invalidate a generic’s ANDA, which can postpone the generic’s entry, though the underlying patent remains time‑bound. These legal battles can extend market exclusivity for a few months to a few years, but they do not alter the patent’s statutory lifespan [1].

Sources
[1] https://www.drugpatentwatch.com/